175P A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC)
Yanhong Gu, X. Chen, D. Wang, Man-Hua Ding, Lijun Xue, Fuxi Zhen, Jing Xu, M. Wang, Yao Li, Nana Sun, C. Liu, Lingyan Xu, Y. Wang, Jiwei Luo
Topics & Concepts
MedicineEsophagectomyOncologyEsophageal cancerChemotherapyCisplatinInternal medicineChemoradiotherapyPaclitaxelStage (stratigraphy)Neoadjuvant therapyCancerSurgeryBreast cancerBiologyPaleontologyEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersGastric Cancer Management and Outcomes